Merck KGaA (FRA:MRK) received a €101.00 ($112.22) price target from equities research analysts at Berenberg Bank in a research note issued to investors on Tuesday. The brokerage currently has a a “neutral” rating on the stock.

A number of other research firms also recently weighed in on MRK. Commerzbank AG set a €101.00 ($112.22) price target on Merck KGaA and gave the company a “buy” rating in a research note on Friday, July 22nd. Citigroup Inc. set a €115.00 ($127.78) price target on Merck KGaA and gave the company a “buy” rating in a research note on Tuesday, July 26th. JPMorgan Chase & Co. restated a “neutral” rating on shares of Merck KGaA in a research note on Thursday, July 21st. Deutsche Bank AG set a €110.00 ($122.22) price target on Merck KGaA and gave the company a “buy” rating in a research note on Thursday, July 28th. Finally, DZ Bank AG restated a “buy” rating on shares of Merck KGaA in a research note on Thursday, July 14th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and eleven have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of €100.55 ($111.72).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Merck KGaA (FRA:MRK) opened at 97.72 on Tuesday. Merck KGaA has a one year low of €70.87 and a one year high of €100.00. The stock’s 50 day moving average price is €96.55 and its 200-day moving average price is €87.51. The firm has a market capitalization of €42.49 billion and a price-to-earnings ratio of 30.58.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/merck-kgaa-mrk-pt-set-at-101-00-by-berenberg-bank.html

Merck KGaA Company Profile

.

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.